10-Q Filing

LifeMD, Inc. CIK: 948320 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001213900-16-018505`
Period End Date	20160930
Filing Date	20161114
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	immd-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 68 Cash Flow Statement 57 Stockholders Equity 18

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$473.92K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	34.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	200,000.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$73.86K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.01M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.01M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$474.92K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	34.68M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$154.44K	USD	Point-in-time
Inventory, net	`InventoryNet`	$130.53K	USD	Point-in-time
Inventory, net	`InventoryNet`	$61.05K	USD	Point-in-time
Treasury stock, common, shares	`TreasuryStockCommonShares`	-	shares	Point-in-time
Treasury stock, common, shares	`TreasuryStockCommonShares`	19,363.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.08M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$448.47K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$167.48K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$408.19K	USD	Point-in-time
Notes payable, net of discount	`NotesPayableCurrent`	$214.12K	USD	Point-in-time
Notes payable, net of discount	`NotesPayableCurrent`	$100.00K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$267.48K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$622.31K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,697,875 and 32,010,375 shares issued, 34,678,512 and 32,010,375 outstanding as of September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$346.98K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,697,875 and 32,010,375 shares issued, 34,678,512 and 32,010,375 outstanding as of September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$46.00K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,697,875 and 32,010,375 shares issued, 34,678,512 and 32,010,375 outstanding as of September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$320.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.37M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.03M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-9.08M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.59M	USD	Point-in-time
Equity	`Equity`	$100.08K	USD	Point-in-time
Equity	`Equity`	$304.69K	USD	Point-in-time
Treasury stock,19,363 shares, at cost	`TreasuryStockValue`	-	USD	Point-in-time
Treasury stock,19,363 shares, at cost	`TreasuryStockValue`	$4.72K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' Equity	`StockholdersEquity`	$299.97K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' Equity	`StockholdersEquity`	$100.08K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$157.09K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$80.91K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.07K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$448.47K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.08M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net sales	`Revenues`	$1.38M	USD	1 Quarter
Net sales	`Revenues`	$279.88K	USD	1 Quarter
Net sales	`Revenues`	$845.51K	USD	3 Qtrs
Net sales	`Revenues`	$4.25M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$2.98M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$73.99K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$237.71K	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$942.74K	USD	1 Quarter
Gross Profit	`GrossProfit`	$607.81K	USD	3 Qtrs
Gross Profit	`GrossProfit`	$441.69K	USD	1 Quarter
Gross Profit	`GrossProfit`	$1.27M	USD	3 Qtrs
Gross Profit	`GrossProfit`	$205.90K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$361.83K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$101.14K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$301.30K	USD	3 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$1.08M	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$82.61K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$277.28K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$29.24K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$91.06K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$382.86K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$57.58K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$204.96K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$206.84K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$599.20K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$649.39K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$187.95K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.74M	USD	3 Qtrs
Operating Income (Loss)	`OperatingIncomeLoss`	$-466.43K	USD	3 Qtrs
Operating Income (Loss)	`OperatingIncomeLoss`	$17.94K	USD	1 Quarter
Operating Income (Loss)	`OperatingIncomeLoss`	$-207.70K	USD	1 Quarter
Operating Income (Loss)	`OperatingIncomeLoss`	$8.61K	USD	3 Qtrs
Interest (expense)	`InterestExpense`	$14.42K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$15.80K	USD	3 Qtrs
Interest (expense)	`InterestExpense`	$9.99K	USD	1 Quarter
Interest (expense)	`InterestExpense`	$33.05K	USD	3 Qtrs
Net Income (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-217.70K	USD	1 Quarter
Net Income (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.52K	USD	1 Quarter
Net Income (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.44K	USD	3 Qtrs
Net Income (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-482.24K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-13.20K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.60K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$8.12K	USD	1 Quarter
Net Income (Loss)	`ProfitLoss`	$-482.24K	USD	3 Qtrs
Net Income (Loss)	`ProfitLoss`	$-11.24K	USD	3 Qtrs
Net Income (Loss)	`ProfitLoss`	$-217.70K	USD	1 Quarter
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.96K	USD	1 Quarter
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.44K	USD	3 Qtrs
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-226.65K	USD	1 Quarter
Net income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-488.68K	USD	3 Qtrs
Net income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-11.24K	USD	3 Qtrs
Net income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$8.12K	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$30.65M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$34.43M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$31.92M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$30.66M	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$31.92M	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$30.65M	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$34.43M	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$30.66M	USD	3 Qtrs

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net (Loss)	`ProfitLoss`	$8.12K	USD	1 Quarter
Net (Loss)	`ProfitLoss`	$-482.24K	USD	3 Qtrs
Net (Loss)	`ProfitLoss`	$-11.24K	USD	3 Qtrs
Net (Loss)	`ProfitLoss`	$-217.70K	USD	1 Quarter
Depreciation	`Depreciation`	$43.75K	USD	3 Qtrs
Depreciation	`Depreciation`	-	USD	3 Qtrs
Bad debt provision	`ProvisionForDoubtfulAccounts`	$-43.56K	USD	3 Qtrs
Bad debt provision	`ProvisionForDoubtfulAccounts`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$5.99K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$5.99K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-13.20K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.60K	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$493.22K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$14.50K	USD	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	-	USD	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	$20.59K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$276.93K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$116.75K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-1.58K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$69.48K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$240.71K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.06K	USD	3 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-111.70K	USD	3 Qtrs
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-80.31K	USD	3 Qtrs
Investment in subsidiary by noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$161.35K	USD	3 Qtrs
Investment in subsidiary by noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	3 Qtrs
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	$150.00K	USD	3 Qtrs
Increase in notes payable	`IncreaseDecreaseInNotesPayableCurrent`	$205.00K	USD	3 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$115.52K	USD	3 Qtrs
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	-	USD	3 Qtrs
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$46.00K	USD	3 Qtrs
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-10.80K	USD	3 Qtrs
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-4.72K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.68K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$352.63K	USD	3 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$240.94K	USD	3 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.63K	USD	3 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$473.92K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$73.86K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$473.92K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$75.50K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$73.86K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$8.56K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaid`	$24.55K	USD	3 Qtrs
Issuance of common stock for notes payable	`ConversionOfStockAmountIssued1`	-	USD	3 Qtrs
Issuance of common stock for notes payable	`ConversionOfStockAmountIssued1`	$10.20K	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`IssuanceOfCommonStockInRelationToDebtOffering`	-	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`IssuanceOfCommonStockInRelationToDebtOffering`	$41.88K	USD	3 Qtrs
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$581.09K	USD	3 Qtrs
Issuance of common stock for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.07K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Amortization of stock options	`AdjustmentsOfAdditionPaidInCapitalAmortizationOfStockOptions`	$133.32K	USD	3 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$306.67K	USD	3 Qtrs
Sale of common stock and warrants	`StockIssuedDuringPeriodValueNewIssues`	$46.00K	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$41.88K	USD	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	-	USD	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	$20.59K	USD	3 Qtrs
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$-4.72K	USD	3 Qtrs
Issuance of stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$53.23K	USD	3 Qtrs
Investment in subsidiary by noncontrolling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$161.35K	USD	3 Qtrs
Net (loss)	`ProfitLoss`	$8.12K	USD	1 Quarter
Net (loss)	`ProfitLoss`	$-482.24K	USD	3 Qtrs
Net (loss)	`ProfitLoss`	$-11.24K	USD	3 Qtrs
Net (loss)	`ProfitLoss`	$-217.70K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.07K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.